Brief: Anika Therapeutics Enters Fifth Amendment To Credit Agreement - SEC Filing
14/07/2026 22:03
BRIEF-Anika Therapeutics Enters Fifth Amendment To Credit Agreement - SEC Filing July 14 (Reuters) - SEC Filing:
ANIKA THERAPEUTICS - ENTERS FIFTH AMENDMENT TO CREDIT AGREEMENT ON JULY 10, 2026 - SEC FILING
ANIKA THERAPEUTICS - SECURES $50 MILLION REVOLVING CREDIT LINE MATURING JULY 10, 2031 - SEC FILING
Source text: [ID:n0001171843-26-004635]
Further company coverage: ANIK.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Anika Therapeutics
See all newsAnika Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Anika Therapeutics Q2 revenue rises, lifts 2026 outlook
Anika Therapeutics Inc expected to post a loss of 8 cents a share - Earnings Preview
Brief: Anika Therapeutics Enters Fifth Amendment To Credit Agreement - SEC Filing
Anika Therapeutics Q1 revenue rises 13%